To evaluate the attitude of pre menopausal women with breast cancer faced with the risk of loss of fertility caused by chemotherapy using EORTC's Fertility Questionnaire.
To characterize the attitude of pre menopausal patients with breast cancer regarding the risks of infertility based on the following variables: * Age at diagnosis * Number of children * Will of having children * Marital status * Scholarity * Period of time from the diagnosis * Time of the last menstruation period * Chemotherapy administration * Clinical staging at the diagnosis * Pathological evaluation * Documentation of the cancer therapy
Study Type
OBSERVATIONAL
Enrollment
343
CPO - Pucrs
Porto Alegre, Rio Grande do Sul, Brazil
HCPA
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Pérola Byington
São Paulo, Brazil
Instituto Nacional de Oncologia y Radiobiologia
Havana, Cuba
To analyze the number of pre-menopausal patients diagnosed with breast cancer that did not agree in receiving chemotherapy due to the risk of infertility
Time frame: Baseline and 1 year after after the first interview
Infertility risk for breast cancer patients after accepting chemotherapy
Time frame: Baseline and 1 year after the first interview
Minimal percentage of cure necessary for patients accept the chemotherapy treatment
Time frame: Baseline and 1 year after the first interview
Age when diagnosed
Time frame: Baseline and 1 year after the first interview
Number of children
Time frame: Baseline and 1 year after the first interview
Desire to have kids
Time frame: Baseline and 1 year after the first interview
Marital status
Time frame: Baseline
Scholarity
Time frame: Baseline
Period of time since the diagnosis
Time frame: Baseline
Chemotherapy scheme administration
Time frame: Baseline and 1 year after the first interview
Period of time from the last menstruation period
Time frame: Baseline and 1 year after the first interview
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cenro Oncologico Estatal ISSEMYM
Toluca, Mexico
INEN
Surquillo, Peru
Hospital de Clínicas San Agustín
Puerto Cabello, Venezuela
Description of quality of life of patients with the EORTC QLQ-BR23
Time frame: Baseline and 1 year after the first interview